TD Cowen Maintains Buy on HCA Healthcare, Lowers Price Target to $431

Benzinga Newsdesk www.benzinga.com Neutral 53.6%

Neg 0% Neu 53.6% Pos 0%

TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $500 to $431.